Danish pharmaceutical company Novo Nordisk has announced it is lowering the U.S.

Insurers have been pushing back against a Medicare Advance Notice on payment rates and a Risk Adjustment Data Validation (RADV) final rule they say will affect consumers and taxpayers.

The Centers for Medicare and Medicaid Services has announced 27 prescription drugs for which Part B beneficiary coinsurances may be lower starting April 1 through June 30.  Lower Part B coinsurance will go into effect on April 1 and will be reviewed quarterly. This coinsurance adjustment applies to certain drugs and biologicals covered under Medicare […]